Haitong Securities
-
Chinese IPO are slowly moving towards a market driven pricing mechanism, reflected by the plummet in share prices on debut -
Chinese biotech firm underperforms on first trading day but quickly recouped most of the losses
-
Chinese regional lender taps Hong Kong shareholders
-
Trust offers unsubscribed rights issue units to investors
-
AI firm relaunches listing with bigger cornerstone allocation and slightly different bookrunning group
-
Artificial intelligence software developer to refund retail investors amid IPO uncertainty
-
Shenzhen-traded pharma firm prices Hong Kong IPO high
-
-
Chinese trio launch IPOs, giving a fresh fillip to the city's equity capital market
-
-
Three large listings hit the market, signaling a pick-up in sentiment
-
State-backed duty-free firm and AI developer ready jumbo December listings
